BOTTOM BU$$TERS

[bb money]

ABPH had some news come out after close might be a good one tomorrow.

BOHEMIA, N.Y., Dec 17, 2007 (BUSINESS WIRE) -- Advanced BioPhotonics Inc announced today that it has completed its initial phase and review of the clinical trial protocol previously announced earlier this year. This trial is investigating the use of Advanced BioPhotonics' patented BioScanIR(R) System, together with its proprietary DIRI(R) method of dynamic infrared imaging in detecting and assessing pigmented lesions of the skin including melanoma and other forms of skin cancer.
In a review of the first twenty-four cases, the BioScanIR(R) was able to correctly identify all four melanomas including a melanoma in situ as well as accurately identifying 80% of the benign lesions as confirmed by biopsy and/or clinical examination.
Although this phase is a small sample size, the principal investigator at the institution called the findings encouraging and promising. The next phase of the study will focus on lesion characterization to help further improve the system's performance. It is expected that the next phase will take several months to complete.